Natco Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE987B01026
NSEID: NATCOPHARM
BSEID: 524816

INR

917.90

3.05 (0.33%)

BSENSE

Dec 19

BSE+NSE Vol: 8.97 lacs

{
  "main_header": {
    "sid": 156274,
    "name": "Natco Pharma",
    "stock_name": "Natco Pharma",
    "full_name": "Natco Pharma Ltd.",
    "name_url": "stocks-analysis/natco-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "917.90",
    "chg": 3.05,
    "chgp": "0.33%",
    "dir": 1,
    "prev_price": "914.85",
    "mcapval": "16,725.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524816,
    "symbol": "NATCOPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE987B01026",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "8.97 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/natco-pharma-156274-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Natco Pharma’s Evaluation Revised Amid Mixed Financial and Market Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/natco-pharma-upgraded-from-sell-to-hold-by-marketsmojo-on-17-nov-2025-3762141",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_mojoScore_3762141.png",
        "date": "2025-12-18 10:10:57",
        "description": "Natco Pharma has experienced a revision in its market evaluation, reflecting nuanced shifts across key analytical parameters. This adjustment highlights a complex interplay of financial trends, valuation considerations, and technical factors within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Natco Pharma Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-technical-momentum-shifts-amid-mixed-indicator-signals-3759278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_technicaldot_3759278.png",
        "date": "2025-12-16 08:01:25",
        "description": "Natco Pharma, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively paint a nuanced picture of the stock’s near-term trajectory."
      },
      {
        "title": "Natco Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-technical-momentum-shifts-amid-mixed-market-signals-3758213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_technicaldot_3758213.png",
        "date": "2025-12-15 08:00:21",
        "description": "Natco Pharma's recent technical indicators reveal a nuanced shift in price momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock's movement, combined with key technical parameters such as MACD, RSI, and moving averages, suggests a sideways trend following a period of mild bearishness, prompting a closer examination of its market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Natco Pharma Sees Elevated Trading Activity Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-surges-on-heavy-value-trading-and-institutional-interest-3756530",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_most_active_equities_by_value_3756530.png",
        "date": "2025-12-11 15:00:10",
        "description": "Natco Pharma Ltd. emerged as one of the most actively traded stocks by value on 11 December 2025, registering significant market interest with a total traded volume exceeding 54 lakh shares and a turnover surpassing ₹501 crore. The stock outperformed its Pharmaceuticals & Biotechnology sector peers and the broader Sensex, reflecting notable investor focus and liquidity in the small-cap pharmaceutical space."
      },
      {
        "title": "Natco Pharma Hits Intraday High with Strong 7.58% Surge in Trading",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-hits-intraday-high-with-714-surge-on-11-dec-2025-3756495",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_priceRelatedfactors_3756495.png",
        "date": "2025-12-11 13:37:11",
        "description": "Natco Pharma recorded a robust intraday performance on 11 Dec 2025, touching a high of Rs 933.25, reflecting a 7.58% rise during the trading session. This surge marks a notable rebound following four consecutive days of decline, positioning the stock well above its key moving averages."
      },
      {
        "title": "Why is Natco Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-natco-pharma-fallingrising-3755636",
        "imagepath": "",
        "date": "2025-12-11 00:34:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Natco Pharma's share price has been under pressure over the past week, registering a decline of 7.17%, significantly underperforming the broader Sensex index, which fell by only 0.84% in the same period. This underperformance is further highlighted by the stock's four consecutive days of losses, accumulating an 8.57% drop in returns during this stretch. Intraday trading on 10-Dec saw the stock touch a low of ₹864.50, marking a 3.18% dip from previous levels.</p>\n<p>Despite this short-term weakness, the stock has shown resilience over the past month with an 8.65% gain, outperforming the Sensex's 1.02% rise. However, the longer-term picture remains challenging. Year-to-date, Natco Pharma's shares have declined by 37.45%, contrasting shar..."
      },
      {
        "title": "Natco Pharma Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-technical-momentum-shifts-amid-mixed-indicator-signals-3752631",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_technicaldot_3752631.png",
        "date": "2025-12-09 08:01:54",
        "description": "Natco Pharma has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company."
      },
      {
        "title": "Is Natco Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-natco-pharma-technically-bullish-or-bearish-3745316",
        "imagepath": "",
        "date": "2025-12-04 08:23:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Technical Trend</strong></p>\n<p>As of 03 December 2025, Natco Pharma's technical trend has transitioned from mildly bearish to sideways. This shift indicates a period of consolidation where neither buyers nor sellers dominate decisively. Such sideways trends often precede significant price moves, making it crucial for investors to monitor further developments closely.</p>\n<p>The stock closed at ₹934.55, marginally up from the previous close of ₹933.45. Intraday price action ranged between ₹923.50 and ₹944.40, reflecting moderate volatility within a relatively narrow band. The 52-week price range remains wide, with a low of ₹660.05 and a high of ₹1,504.00, underscoring the stock's historical price swings.</p>\n<p><strong>Weekly Technical Indicators: Mildly Bullish Signals</..."
      },
      {
        "title": "Natco Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/natco-pharma-technical-momentum-shifts-to-sideways-mixed-indicator-signals-emerge-3745159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NatcoPharma_technicaldot_3745159.png",
        "date": "2025-12-04 08:00:30",
        "description": "Natco Pharma has exhibited a notable shift in its technical momentum, transitioning from a mildly bearish stance to a more sideways trend. This change is underscored by a complex interplay of technical indicators across weekly and monthly timeframes, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company."
      }
    ],
    "total": 5584,
    "sid": "156274",
    "stock_news_url": "https://www.marketsmojo.com/news/natco-pharma-156274"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "02-Dec-2025",
      "details": "Appointment of Mr. Amit Parekh as Executive Vice President - Finance & Accounts w.e.f. 2nd December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "29-Nov-2025",
      "details": "Intimation of Credit Rating",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "21-Nov-2025",
      "details": "Conclusion of USFDA inspection at our Manali Chennai API unit",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has declared <strong>75%</strong> dividend, ex-date: 20 Nov 25",
          "dt": "2025-11-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Natco Pharma Ltd. has announced <strong>2:10</strong> stock split, ex-date: 26 Nov 15",
          "dt": "2015-11-26",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Natco Pharma’s Evaluation Revised Amid Mixed Financial and Market Signals

2025-12-18 10:10:57

Natco Pharma has experienced a revision in its market evaluation, reflecting nuanced shifts across key analytical parameters. This adjustment highlights a complex interplay of financial trends, valuation considerations, and technical factors within the Pharmaceuticals & Biotechnology sector.

Natco Pharma Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-16 08:01:25

Natco Pharma, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively paint a nuanced picture of the stock’s near-term trajectory.

Natco Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-15 08:00:21

Natco Pharma's recent technical indicators reveal a nuanced shift in price momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock's movement, combined with key technical parameters such as MACD, RSI, and moving averages, suggests a sideways trend following a period of mild bearishness, prompting a closer examination of its market positioning within the Pharmaceuticals & Biotechnology sector.

Natco Pharma Sees Elevated Trading Activity Amid Sector Outperformance

2025-12-11 15:00:10

Natco Pharma Ltd. emerged as one of the most actively traded stocks by value on 11 December 2025, registering significant market interest with a total traded volume exceeding 54 lakh shares and a turnover surpassing ₹501 crore. The stock outperformed its Pharmaceuticals & Biotechnology sector peers and the broader Sensex, reflecting notable investor focus and liquidity in the small-cap pharmaceutical space.

Natco Pharma Hits Intraday High with Strong 7.58% Surge in Trading

2025-12-11 13:37:11

Natco Pharma recorded a robust intraday performance on 11 Dec 2025, touching a high of Rs 933.25, reflecting a 7.58% rise during the trading session. This surge marks a notable rebound following four consecutive days of decline, positioning the stock well above its key moving averages.

Why is Natco Pharma falling/rising?

2025-12-11 00:34:34

Recent Price Movement and Market Context

Natco Pharma's share price has been under pressure over the past week, registering a decline of 7.17%, significantly underperforming the broader Sensex index, which fell by only 0.84% in the same period. This underperformance is further highlighted by the stock's four consecutive days of losses, accumulating an 8.57% drop in returns during this stretch. Intraday trading on 10-Dec saw the stock touch a low of ₹864.50, marking a 3.18% dip from previous levels.

Despite this short-term weakness, the stock has shown resilience over the past month with an 8.65% gain, outperforming the Sensex's 1.02% rise. However, the longer-term picture remains challenging. Year-to-date, Natco Pharma's shares have declined by 37.45%, contrasting shar...

Natco Pharma Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-09 08:01:54

Natco Pharma has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This change is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company.

Is Natco Pharma technically bullish or bearish?

2025-12-04 08:23:23

Overview of Current Technical Trend

As of 03 December 2025, Natco Pharma's technical trend has transitioned from mildly bearish to sideways. This shift indicates a period of consolidation where neither buyers nor sellers dominate decisively. Such sideways trends often precede significant price moves, making it crucial for investors to monitor further developments closely.

The stock closed at ₹934.55, marginally up from the previous close of ₹933.45. Intraday price action ranged between ₹923.50 and ₹944.40, reflecting moderate volatility within a relatively narrow band. The 52-week price range remains wide, with a low of ₹660.05 and a high of ₹1,504.00, underscoring the stock's historical price swings.

Weekly Technical Indicators: Mildly Bullish SignalsRead More

Natco Pharma Technical Momentum Shifts Amid Mixed Market Signals
2025-12-04 08:00:30
Natco Pharma has exhibited a notable shift in its technical momentum, transitioning from a mildly bearish stance to a more sideways trend. This change is underscored by a complex interplay of technical indicators across weekly and monthly timeframes, reflecting a nuanced market assessment for the pharmaceutical and biotechnology company.
Read More